36

Ascentage Pharma Group InternationalFRA Ascentage Pharma Stock Report

Last reporting period 31 Dec, 2023

Updated 28 Oct, 2024

Last price

Market cap $B

1.619

Small

Exchange

XFRA - Deutsche Boerse AG

View Section: Price ratios

Ascentage Pharma Statements

36

Data from Ascentage Pharma`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

CNY - Chinese yuan

Last reporting period:

31 Dec, 2023

Next reporting period:

28 Jun, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

Ascentage Pharma Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

CNY (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-12-31
%

79.283

-44.4 %

100

12.389

15.6

66.894

-46.3 %

84.4

397.16

500.9

201.8

254.5

585.7

21.9 %

738.7

-518.8

-45.8 %

-654.4

-14.459

-18.2

0

-533.26

-33.4 %

-672.6

-9.896

-12.5

-523.29

-30.1 %

-660.02

-1.804

290.05

2023-06-30
%

142.7

25.2 %

100

18.154

12.7

124.55

28.4 %

87.3

309.81

217.1

174.66

122.4

480.48

-13.5 %

336.7

-355.93

22.4 %

-249.4

-43.67

-30.6

0

-399.6

17.6 %

-280.03

2.746

1.9

-402.35

15.5 %

-282

-1.465

274.55

2022-12-31
%

113.95

19 %

100

16.977

14.9

96.971

6.9 %

85.1

401.69

352.5

174.33

153

555.4

11.6 %

487.4

-458.43

-12.7 %

-402.3

-26.482

-23.2

0

-484.92

-20.6 %

-425.6

-8.73

-7.7

-476.19

-17.1 %

-417.9

-1.806

263.66

2022-06-30
%

95.763

540.8 %

100

5.021

5.2

90.742

538.8 %

94.8

341.41

356.5

153.69

160.5

497.65

-11.4 %

519.7

-406.9

25.6 %

-424.9

2.58

2.7

0

-402.25

12.1 %

-420.05

4.482

4.7

-406.73

-0.2 %

-424.7

-1.543

263.67

2021-12-31
%

14.945

15.3 %

100

0.739

4.9

14.206

36.9 %

95.1

448.95

3004

116.74

781.1

561.41

46.5 %

3756.5

-547.2

-46.7 %

-3661.4

89.327

597.7

0

-457.87

-22.3 %

-3063.7

-52.131

-348.8

-405.74

-7.7 %

-2714.9

-1.548

262.17

2021-06-30
%

12.965

31.8 %

100

2.589

20

10.376

31.8 %

80

317.54

2449.2

74.52

574.8

383.28

2.9 %

2956.3

-372.91

-2.3 %

-2876.2

-1.471

-11.3

0

-374.38

-5.3 %

-2887.6

2.306

17.8

-376.68

-5.1 %

-2905.4

-1.525

247.06

2020-12-31
%

9.837

276.5 %

100

1.966

20

7.871

80

313.12

3183

68.643

697.8

372.31

12.1 %

3784.8

-364.44

-10.6 %

-3704.8

8.97

91.2

0

-355.47

-11.1 %

-3613.6

2.959

30.1

-358.43

-12.3 %

-3643.7

-1.608

222.92

2020-06-30
%

2.613

-78.6 %

100

0

0

251.46

9623.2

61.699

2361.2

332.03

-61.6 %

12707

-329.42

61.4 %

-12607

9.442

361.3

0

-319.98

62.3 %

-12245.6

-0.801

-30.7

-319.18

62.3 %

-12215

-1.528

208.9

2019-12-31
%

12.196

426.4 %

100

2.096

17.2

10.1

335.9 %

82.8

264.9

2172

99.853

818.7

863.88

33.9 %

7083.3

-853.78

-32.8 %

-7000.5

5.577

45.7

0

-848.2

-33.8 %

-6954.7

-0.801

-6.6

-847.4

-33.8 %

-6948.2

-21.976

38.561

2019-06-30
%

2.317

100

0

2.317

100

198.98

8587.9

61.79

2666.8

645.13

27843.2

-642.81

-27743.2

8.693

375.2

0

-634.12

-27368

-0.801

-34.6

-633.32

-27333.4

-3.25

194.89

View Section: Balance Sheet